PE-VC Fund Investments
Digital health-focused semiconductor maker Sophrosyne bags $2-M from Bluehill Capital
Bengaluru-based semiconductor startup Sophrosyne Technologies has raised USD 2 million (about INR 17.7 crore) in a seed funding round from early-stage venture capital firm Bluehill Capital. This funding follows a USD 1.2 million design-linked incentive (DLI) grant the company got from the Ministry of Electronics and Information Technology (MeitY).Founded in 2022 by Manish Srivastava, Sophrosyne is focused on developing multi-vital biosensing system-on-chip (SoC) solutions for wearable and digital health devices. The startup is also developing proprietary AI models for advanced signal processing, deep learning, and on-edge optimisation to convert physiological data into actionable health insights.The new funds will be used to accelerate the transition from prototype silicon to full-scale product commercialisation, expand silicon and firmware design teams, and grow early customer deployments both within India and globally.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
